InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
2
T+90 胜率
100%
T+90 平均收益
+37.0%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Hung David, 董事. Insider active across 3 companies, notably NovoCure Ltd. Cumulatively, 9 reports have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €1.1m. Activity tracked since 9 June 2021. The latest transaction was disclosed on 16 June 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hung David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
500,000 股@ US$1.78772.0% 占其流量Class A Common StockSEC:0001415889-25-017656:0
标准退出：2025年9月14日 (T+90)
11,215 股0Ordinary SharesSEC:0001562180-25-004556:0
999 股@ US$17.2968100.0% 占其流量Ordinary SharesSEC:0001562180-25-004428:0
200,000 股@ US$1.6636100.0% 占其流量Class A Common StockSEC:0001415889-25-010446:0
标准退出：2025年7月3日 (T+90)
4,053 股0Restricted Stock UnitsSEC:0001562180-24-004768:0
368,408 股0Class A Common StockSEC:0001209191-23-014890:0
2,427 股0Restricted Stock UnitsSEC:0001645113-22-000054:0
814 股0Restricted Stock UnitsSEC:0001645113-21-000075:0
6,350 股Common StockSEC:0001209191-16-096111:0
9 条申报中的 9 条
About Hung David
Hung David is Administrateur at NovoCure Ltd, PRESIDENT AND CEO at Nuvation Bio Inc., and President and CEO at MEDIVATION, INC. He appears in 9 filings, and across the 9 sampled filings between 2016-02-05 and 2025-06-18, purchases total EUR 1074778 and sales EUR 15178, with the dominant transaction nature listed as Attribution.
